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Phosphopantetheine transferases represent a class
of enzymes found throughout all forms of life. From
a structural point of view, they are subdivided into
three groups, with transferases from group II being
the most widespread. They are required for the post-
translational modification of carrier proteins involved
in diverse metabolic pathways. We determined the
crystal structure of the group II phosphopantetheine
transferase Sfp from Bacillus in complex with a sub-
strate carrier protein in the presence of coenzyme A
and magnesium, and observed two protein-protein
interaction sites. Mutational analysis showed that
only the hydrophobic contacts between the carrier
protein’s second helix and the C-terminal domain of
Sfp are essential for their productive interaction.
Comparison with a similar structure of a complex of
human proteins suggests that the mode of interac-
tion is highly conserved in all domains of life.
INTRODUCTION
Carrier-protein-driven synthesis of primary and secondary
metabolites is an essential process in every organism (Crosby
and Crump, 2012). Among these carrier proteins, the acyl carrier
protein or domain (ACP) of fatty acid synthase (FAS) is conserved
throughout all kingdoms of life (Chan and Vogel, 2010). Its fold
with a four-helix bundle as the structural core (Figure 1A) is found
not only in FAS but also in many other biosynthetic pathways,
ranging from peptidyl carrier proteins (PCPs) in nonribosomal
peptide synthetases (NRPSs) (Condurso and Bruner, 2012; Hur
et al., 2012) and ACPs in polyketide synthases (PKSs) (Kea-
tinge-Clay, 2012), which aremainly present in bacteria and fungi,
to carrier proteins that shuttle intermediates for metabolism of
lysine in yeast (Ehmann et al., 1999) and humans (Praphanphoj
et al., 2001). The posttranslational conversion of carrier proteins552 Chemistry & Biology 21, 552–562, April 24, 2014 ª2014 Elsevierinto their holo form is a prerequisite for their function. This is
accomplished by phosphopantetheinylation of the hydroxyl
group of a conserved serine side chain located at the N terminus
of the second helix. A conformational equilibrium has been
described for TycC3_PCP, the third PCP domain of the tyroci-
dine A synthetase subunit C from Bacillus brevis (Koglin et al.,
2006). Besides the common four-helix bundle structure referred
to as the A/H state, a second conformer exists for the apo-PCP
lacking the 40-phosphopantetheine (ppan) cofactor. In this so-
called A state, the third helix is disordered and all other helices
are shortened, resulting in a partly unfolded and therefore
more flexible structure.
All phosphopantetheine transferases (PPTs) (Beld et al., 2014),
which catalyze the transfer of the cofactor derived from
coenzyme A (CoA) (Figure 1C) onto a carrier protein, share a
fundamental domain that comprises a central, three-stranded,
antiparallel b sheet with a b1/b3/b2 topology and a stretch of
80 amino acids inserted between the first two b strands. This
stretch adopts a mainly helical fold located on one side of the
b sheet, whereas the other side acts as an oligomerization inter-
face (Figure 1B). The formation of oligomers is essential for the
function of the PPT, as the active site with the binding pocket
for CoA and the carrier protein is formed by the interface of
two monomers.
Structurally, three different groups of PPTs can be distin-
guished. Holo acyl carrier protein synthases (AcpSs) represent
the first group (Elovson and Vagelos, 1968). Consisting of an
intermolecular trimer of single PPT domains (Parris et al.,
2000), they are found in most bacteria as the modifying enzyme
for the ACP of FAS. The PPTs of group III are mainly found in
fungi, where the FAS is composed of multidomain peptide
chains containing a PPT domain (Fichtlscherer et al., 2000). In
the active megasynthase, these PPT domains are located on
the outside as separated, nonfunctional monomers that are in-
capable of interacting with the ACP domain (Lomakin et al.,
2007). Investigations of the excised PPT domain of the FAS
from yeast showed that it forms catalytic trimers analogous to
group I PPTs, and it was proposed that this situation occurs
during the assembly of the active FAS enzyme complex (Johans-
son et al., 2009).Ltd All rights reserved
Figure 1. The Key Elements of Phosphopantetheinylation
(A) Carrier proteins consist of four helices, with the conserved serine located at
the N terminus of the second helix.
(B) In type II PPTs, an N-terminal PPT domain (gray) and a C-terminal PPT
domain (colored) are connected by a short linker (dashed line). Each PPT
domain consists of a central b sheet (red) with a mainly helical insert (purple)
between the first two strands. The C terminus of the protein forms an extended
region (green) that embraces the N-terminal PPT domain. The two PPT do-
mains interact via their central b sheets, thus forming the binding pocket for
CoA and the interface for the interaction with the carrier protein (asterisk).
(C) During the reaction, the ppan moiety (black) of CoA is transferred onto the
carrier protein with 30,50-adenosine bisphosphate (gray) as a side product.
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Chemistry & Biology 21,In contrast to the two other types, PPTs from group II harbor
two fused PPT domains within one protein (Lambalot et al.,
1996). Thus, they do not oligomerize in an intermolecular fashion,
but act as single proteins that can be seen as intramolecular
pseudo-dimers (Reuter et al., 1999). In microorganisms, PPTs
of group II are involved in secondary metabolism, and it has
been shown that they are capable of modifying the ACPs of
primary metabolism in vitro (Lambalot et al., 1996). Their high
tolerance with respect to carrier proteins accepted as a sub-
strate may explain why the sole human PPT is a member of
this group (Praphanphoj et al., 2001).
Sfp, which is required for cofactor loading on the surfactin
NRPS in Bacillus subtilis, is a structurally and functionally well-
characterized group II PPT. It exhibits a broad promiscuity to-
ward CoA derivatives and carrier proteins. Hence, it is frequently
used in biotechnological approaches to load carrier proteins with
ppan conjugated with molecules such as amino acids (Belshaw
et al., 1999), peptides (Sieber et al., 2003), fatty acids (Kosa et al.,
2012), and fluorescent labels (La Clair et al., 2004).
In the present work, we solved the crystal structure of Sfp,
CoA, and the active-site alanine mutant of TycC3_PCP, which
form a stable ternary complex, at 2.0 A˚ resolution. Furthermore,
we solved the structure of TycC3_PCP(S45A) by using liquid-
state NMR techniques, and the results show that, in contrast
to what we proposed in our previous work (Koglin et al., 2006),
the free active-site mutant PCP is in the A/H state conformation
in solution. Based on the structure of the complex, we identified
several motifs involved in the protein-protein interaction. We
investigated the impact of the residues involved on the velocity
of the transfer reaction and the stability of the complex by per-
forming a ppan transfer assay and isothermal titration calorim-
etry (ITC). Remarkably, the key interactions for formation of the
carrier protein/PPT complex seem to be conserved in group II
PPTs from bacteria to humans (Bunkoczi et al., 2007).
RESULTS
Structure of Sfp in Complex with TycC3_PCP(S45A)
An active-site serine-to-alanine mutant of the carrier protein
TycC3_PCP(S45A) was chosen for crystallization in order to
prevent the ppan transfer reaction but still facilitate the formation
of the complex in the presence of CoA. We crystallized the
heterodimeric protein complex consisting of Sfp and TycC3_
PCP(S45A) sandwiching CoA, and solved its structure to a reso-
lution of 2.0 A˚ (Figure 2A).
Sfp within the complex consists of two structurally similar PPT
domains (M1-D100 and I104-A206; root-mean-square deviation552–562, April 24, 2014 ª2014 Elsevier Ltd All rights reserved 553
Figure 2. Structure of the TycC3_PCP(S45A)/Sfp Complex
(A) PCP (cyan) and Sfp (gray) form a complex with CoA (sticks) buried in their interface.
(B) Major differences between free Sfp (blue, PDB 1QR0) and its complex with PCP (semitransparent gray; PCP not shown) are a relocation of the first helix in the
C-terminal PPT domain that widens the binding pocket for PCP and a reorientation of b10/b20of the C-terminal PPT domain (movements with respect to the
location in the structure of free Sfp are indicated by arrows).
(C) The structure of the human ACP/PPT complex (PDB 2CG5) shows a high similarity to the PCP/Sfp complex, although parts of the carrier proteins differ in their
orientation.
See also Table S2.
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Structure of a PCP/Sfp Complex[rmsd] 3.1 A˚ over 94 Ca pairs), each spanning 100 residues,
and a C-terminal extension (A207-L224). Both domains form
the expected central antiparallel b sheet with a b1/b3/b2
arrangement. b1 and b2 are linked by an 80 amino acid insert
containing three a helices (a1, a2, and a3) and an antiparallel b
sheet (b10/b20). Helix a3 is situated diagonally across the central
b sheet. While a1 and a2 cover the N-terminal half of a3, the
C-terminal half interacts with b10/b20. The elongated C terminus
of Sfp passes around b1 and a3 of the N-terminal PPT domain
and ends as a short helix located between b1, a1, and a3 of
the N-terminal PPT domain.
The structure of Sfp within the PCP/Sfp complex resembles
the known type II PPT structure. Compared with the structures
of Sfp in complex with CoA (Reuter et al., 1999) (Protein data
Bank [PDB] 1QR0; Figure 2B) and the human PPT in complex
with CoA and the ACP domain of FAS (Bunkoczi et al., 2007)
(PDB 2CG5; Figure 2C), it shows an rmsd of 1.5 A˚ and
2.0 A˚ over 207 and 221 Ca pairs, respectively. The most prom-
inent differences in comparison with the known Sfp structure are
the reorientation of a1/a2 (K110-Q139) and the loop containing
b10/b20 (G158-S187) in the C-terminal PPT domain. The move-
ment of a1/a2 increases their distance to the N-terminal domain
by 4–5 A˚, resulting in a larger cavity for PCP binding. The 90
flip of the loop harboring b10/b20 is more severe. Although in
both structures the loop is in close proximity to a2, a3, and b2
of Sfp’s second PPT domain, these extended hydrophobic and
polar contacts are formed in the crystal structure of free Sfp by
intermolecular contacts and in the structure of the PCP/Sfp com-
plex in an intramolecular manner.
Cofactor Binding by Sfp
The binding of CoA’s base and sugar, as well as the 30 phosphate
group by Sfp, does not differ between the structures in the pres-
ence and absence of PCP. A Mg ion that is coordinated by CoA
and residues of b1 and a3 of the C-terminal PPT domain is554 Chemistry & Biology 21, 552–562, April 24, 2014 ª2014 Elsevieressential for the transfer reaction. The coordination of this
Mg ion changes between the free Sfp and the PCP/Sfp complex
(Figures 3A and 3B). In the structure without PCP, the Mg ion is
coordinated by side-chain carboxyl groups from D107, E109,
and E151 of Sfp, CoA’s pyrophosphate, and a water molecule.
In the structure of the complex, the carboxyl group of E151 is
rotated by 90, facilitating a 0.6 A˚ shift of the Mg ion toward
the oxygen of the 50 a phosphate accompanied by a slight reor-
ientation of the b phosphate and the water molecule. As a result,
the Mg ion is almost perfectly coordinated in five out of six octa-
hedral positions by D107, E151, CoA’s pyrophosphate, and a
water molecule. Due to the larger distance, E109 can no longer
occupy the sixth position; instead, a second water molecule is
clearly visible in the electron density map at this position. The
position of this water might be further stabilized by a hydrogen
bond to the indole amine of W147. This arrangement is similar
to the one observed in the human PPT with CoA (Bunkoczi
et al., 2007) (PDB 2C43), although the position of the second wa-
ter molecule is more disordered in that structure (Figure 3C).
Another feature of the PCP/Sfp structure is the presence of a
second Mg ion in the active site. It is coordinated by CoA’s 50
a phosphate, the carbonyl and side chain of Sfp’s H90, and three
water molecules. The electron density that we identified as this
second Mg ion was observed in the structures of Sfp and the
human PPT as well, but was assigned as water molecules (Fig-
ures 3D–3F).
In contrast to previous structures, the whole pantetheine
moiety of CoA shows electron density, whereas a discrete
positioning of this part of the cofactor was not observed in the
structure of Sfp in complex with CoA or in the human PPT/ACP
complex. The oxygen atoms of its two amide bonds point toward
Sfp’s L161/S162, and the terminal thiol group is located between
Sfp’s E72/Y73 and helix 3 of the PCP (Figure S1 available online).
Since multiple examples have shown that Sfp is very tolerant
toward modifications of CoA’s thiol group, ranging from aLtd All rights reserved
Figure 3. Coordination of the Magnesium Ions
(A–C) The coordination of the catalytic Mg ion (yellow ball) differs between Sfp’s complex with PCP (A) and the free Sfp (B). The former resembles the situation
in the human PPT (C; PDB 2C43), but in this structure one water molecule (asterisk) shows only weak electron density and is sterically hindered by the side chain
of M141.
(D–F) In the structure of the PCP/Sfp complex, a second Mg ion is present and is coordinated by H90 of Sfp, CoA, and three water molecules (D). In the other
structures, electron density is observed in the same position, but is assigned as a water molecule even though it is similarly coordinated by histidine and CoA
(E and F).
See also Figures S1 and S2.
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Structure of a PCP/Sfp Complexsubstitution with an amino group (Liu and Bruner, 2007;
Worthington and Burkart, 2006) to attachment of amino acids,
peptides, and fatty acids, it is likely that the location of the
pantetheine moiety in solution is more disordered within the
gap between Sfp and the carrier protein than the crystal struc-
ture suggests.
PCP Is Not in the A State
The PCP in complex with Sfp and CoA shows electron density
for its whole helical core, whereas short parts of the N and C
termini (P2-Q7 and S85-H91) are not resolved. According to
mass-spectrometric analysis, M1 is cleaved in vivo (data not
shown). The secondary structure and fold of PCP indicate
clearly that it is in the regular carrier protein conformation (A/H
state) and not in the A state as we proposed previously (Koglin
et al., 2006). To determine which conformation TycC3_
PCP(S45A) adopts in solution, we solved its structure by NMR
spectroscopy. Contrary to the previous prediction, the PCP (Fig-
ure 4) has the same overall fold as observed in the crystallized
complex (rmsd 0.70 A˚).Chemistry & Biology 21,Interaction between Sfp and PCP
Based on the crystal structure, two interaction sites between
PCP and Sfp were detected. The amide hydrogen of Y36 in
Sfp’s N-terminal domain and the backbone carbonyl oxygen of
PCP’s Q40 form an intermolecular hydrogen bond (Figure 5B).
The second,more expanded interaction site comprises nonpolar
contacts between the C-terminal domain of Sfp and the second
helix of PCP. Sfp’s hydrophobic patch is formed by side chains
located in the first helix and the preceding loop (I114, I118, F122,
and F123), and the third helix and the succeeding loop (F143,
Y144, W147, L161, and L165) in the C-terminal domain, respec-
tively. These side chains point toward the binding pocket
between the two PPT domains and form a small cavity. This
cavity is occupied by the side chains of L46 and M49 of PCP’s
second helix (Figures 5C and 5D). Sequence alignments show
that these two positions are always occupied with hydrophobic
residues in carrier proteins that are natural targets of group II
PPTs, and that hydrophobic residues, which probably form the
binding interface for these carrier proteins, are present in diverse
group II PPTs (Figure 5E). In addition, a glycine positioned three552–562, April 24, 2014 ª2014 Elsevier Ltd All rights reserved 555
Figure 4. NMR Investigations on TycC3_PCP(S45A)
The 20 lowest-energy NMR structures of the PCPmutant (A; H86-91 omitted) show that the mutant PCP is not in the A state conformation (B; PDB 2GDY) as was
previously proposed.
See also Table S3.
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Structure of a PCP/Sfp Complexresidues N terminal to the active-site serine occurs in most
carrier proteins. In the structure of the complex, this residue
(G42) has a positive f angle. Thus, it seems to be necessary
for a correct orientation of the hydrogen bond and the hydropho-
bic patches (Figure 5A).
Mutational Analysis of the PCP-Sfp Interaction
To investigate the proposed importance of these amino acids for
the protein-protein interaction, mutants of both proteins were
created. Sfp(Y36P) was generated to destroy the intermolecular
hydrogen bond. In the wild-type (WT) and active-site mutant,
PCP mutations L46A, L46N, L46D or M49D were introduced to
disrupt the hydrophobic interaction, and G42A was introduced
to hinder the correct orientation of the two interaction sites.
Although the G42A mutation abolished the expression in vivo,
the expression in vitro resulted in a protein pellet that could be
refolded after it was dissolved in urea.
All mutant proteins exhibited the same monomeric properties
as the WT proteins when studied by size-exclusion chromatog-
raphy (data not shown), and their correct fold and sufficient
stability were confirmed by circular dichroism spectroscopy
(Figure S3). Changes in the binding of CoA to Sfp(Y36P) were
ruled out by results showing that this mutant had approximately
the same affinity for CoA as Sfp(WT) (Table 1) in an ITC experi-
ment. Furthermore, in vivo and cell-free expressed TycC3_
PCP(S45A) showed similar binding affinities to Sfp(WT) at 5C
with dissociation constants (KD) of 0.74 and 0.94 mM, respec-
tively, whereas the WT carrier protein expressed in vivo and
in vitro behaved virtually identically in the ppan transfer assay
(Figure S4A).
To probe the effect of themutations on the stability of the PCP/
Sfp complex, the PCPmutants harboring the S45Amutation and
WT and mutant Sfp were investigated by ITC. In the presence of
CoA, almost all PCP variants could be titrated with Sfp(WT) at
5C and 25C; only TycC3_PCP(G42A,S45A) was not stable
at the higher temperature. At both temperatures, TycC3_PCP
(S45A) showed comparable KD values of 0.74 mM at 5
C
and 0.92 mM at 25C. TycC3_PCP(G42A,S45A) was the only
double mutant with a detectable but significantly higher KD
(39.7 mM), and the KD for all other mutants was too high to556 Chemistry & Biology 21, 552–562, April 24, 2014 ª2014 Elsevierbe determined by ITC. Titration of Sfp(Y36P) with TycC3_PCP
(S45A) showed no binding at 25C, but at 5C a KD of 54.3 mM
could be determined (Table 1).
To compare the stability of the complex with the velocity of the
phosphopantetheinylation reaction, apo-PCPs with an intact
active-site serine were incubated with Sfp(WT) in the presence
of CoA. The formation of holo-PCPs at different time points
was quantitatively monitored by liquid chromatography/mass
spectrometry analysis and revealed a dependency of the
reaction’s velocity on the mutation in the PCP (Figure 6). The
L46A mutation reduced the reaction speed compared with
TycC3_PCP(WT), whereas the effect of the L46N mutation was
more severe, and TycC3_PCP(L46D) showed hardly any
product formation even after incubation for 1 hr. Introduction
of an aspartate at position 49 had a less drastic effect, and
holo-TycC3_PCP(M49D) was produced considerably faster
than holo-TycC3_PCP(L46N). Unexpectedly, the fastest
turnover was observed for the reactions of TycC3_PCP(G42A)
with Sfp(WT), and for WT PCP incubated with Sfp(Y36P). On
the other hand, the modification of TycC3_PCP(L46N) was
significantly slower when Sfp(WT) was substituted with
Sfp(Y36P) (Figure S4B).
DISCUSSION
In previous investigations (Koglin et al., 2006), we showed that
PCP domains, in both the apo and holo forms, can adopt
different conformations and that these conformations exchange
dynamically with each other. For apo-TycC3_PCP in solution,
double peaks were observed in different NMR spectra. These
two sets of peaks represent the A state and the A/H state confor-
mation, the structures of which we calculated based on nuclear
Overhauser effect (NOE) signals (Koglin et al., 2006). In the same
study, we observed that mutation of the active-site serine of the
PCP to alanine led to the disappearance of one set of peaks, and
we suggested, based on chemical-shift data, that the mutated
PCP is locked in the less well-structured A state conformation.
Furthermore, we proposed a docking model of the PCP/Sfp
complex with the PCP in the A state conformation (Koglin
et al., 2006). However, the structures of isolated TycC3_PCPLtd All rights reserved
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Structure of a PCP/Sfp Complex(S45A) (as determined by NMR) and TycC3_PCP(S45A) in com-
plex with Sfp (as determined by X-ray crystallography), both re-
ported here, now reveal that this mutant adopts the A/H state
conformation. In the docking model, this arrangement was not
possible because the PCP in the A/H state conformation did
not fit into the binding pocket of the Sfp structure determined
by Reuter et al. (1999) that was used for modeling. Here, we
show that the binding pocket of Sfp opens by 5 A˚, so the
PCP in the A/H state conformation can bind (Figure 2B). There
is no evidence that the A state conformation is involved in the
PCP-Sfp interaction. However, the only known functional inter-
action of an apo-PCP is its phosphopantetheinylation by a
PPT. Therefore, the biological function and relevance of the A
state conformation observed for the WT apo-TycC3_PCP are
unknown and require further investigation.
The intermolecular contacts in the structure of Sfp in complex
with CoA were previously referred to as an artifact of crystalli-
zation (Reuter et al., 1999). However, the reorientation of b10/
b20 and a1/a2 indicate a flexibility of this region that might be
related to regulation of the enzyme’s activity. Yet, from this
region only a1 is involved in the formation of the binding interface
for PCP, and the binding pocket for CoA seems to be unaffected
by the rearrangement. Since the PCP in the A/H state conforma-
tion does not fit in the narrow binding pocket of Sfp observed in
the structure of the CoA complex, the relevance of this alter-
native conformation remains unclear. Furthermore, no similar re-
arrangement has been observed in the corresponding structures
of the human PPT (Bunkoczi et al., 2007).
The crystal structure presented here is a PPT/carrier protein
complex in the presence of CoA with a well-resolved active
site including the essential cation and its inner coordination
sphere, and thus provides insights into the catalysis of the
ppan transfer reaction. Three mechanisms for the deprotonation
of the side chain of S45 have been proposed. Based on the
structure of Sfp, direct complexation and activation by the Mg
ion (Reuter et al., 1999) was suggested, whereas mutational
studies on Sfp (Mofid et al., 2004) and human PPT (Bunkoczi
et al., 2007) suggested deprotonation by the conserved gluta-
mate side chain (E151 and E191, respectively). For the Bacillus
AcpS, deprotonation by an activated water molecule was pro-
posed (Parris et al., 2000).
For our structure, we mutated the active-site serine of PCP in
order to suppress the reaction in favor of the formation of a stable
complex; however, it can also be modeled in silico. Modeling of
the hydroxyl group in the ()-gauche conformation brings it into
close proximity to the catalytic center, whereas in the two other
rotamers it is pointing away from the catalytic center. In this
situation, a direct interaction of the hydroxyl group with the Mg
ion seems unlikely due to the distance and geometry (Figure S2).
However, the hydroxyl group is in a plane with one of the water
molecules complexing the Mg ion and the carboxyl groups of
D107, E109, and E151. An interaction with the water molecule
activated by the three acidic side chains or directly with E151
is sterically possible. Further insight into the catalysis might be
derived by neutron scattering to reveal the protonation state of
the active site, but even data from this method would not be
explicit if both reactions occur simultaneously.
In the absence of PCP, it is not desirable to have a high reac-
tivity because this would lead to hydrolysis of the acid anhydrideChemistry & Biology 21,bond. In this situation, the side chain of E109 is coordinated to
the Mg ion and is replaced by a water molecule upon binding
of PCP. This change in the coordination sphere of the Mg ion
could potentially modulate the reactivity. However, since E109
is not conserved, such a modulation would not be a general
mechanism. Thus far, the secondMg ion has not been described
in structures of PPTs. Nevertheless, the environment of thewater
molecules found at the same position in the other structures
indicates that the electron density might represent a Mg ion as
well (Figures 3D–3F). A cation at this position would not only
enhance the binding of CoA to Sfp but would also stabilize
the additional negative charge of the 50 phosphate after ppan
transfer. Mutation of H90 to asparagine or alanine has a distinct,
but not drastic, effect on the ppan transfer by Sfp (Mofid et al.,
2004), although themutation very likely disrupts the coordination
of the second Mg ion and the 30 phosphate of CoA. Therefore, it
can be concluded that the second Mg ion is not essential for the
catalysis or binding of CoA by the PPT.
The high structural similarity of the PCP/Sfp complex and the
human ACP/PPT complex, together with sequential similarities
in different PPTs, indicates that the mechanism of catalysis is
conserved in group II PPTs from many organisms ranging from
bacteria to mammals. The same is true for the recognition of
the carrier protein by the PPT. The intermolecular hydrogen
bond, the hydrophobic contacts between helix 2 of the carrier
protein and the C-terminal domain of the PPT, and the glycine
in the loop required for the proper connection of the two interac-
tions sites are present in both structures.
The effect of certain residues of the PCP involved in a correct
binding to Sfp was shown by site-directed mutagenesis. The
breakup of the intermolecular hydrogen bond by substitution of
the hydrogen-bond donor (Y36 of Sfp) with a proline leads to a
drop in the affinity for PCP by a factor of >70 (KD 0.74 versus
54.3 mM). The binding of Sfp(WT) to the PCP(G42A) mutant
shows a similar drop in affinity, most likely due to a less favorable
geometry for the formation of the intermolecular hydrogen bond,
caused by a reorientation of the loop containing G42.
Remarkably, the reduced affinity does not lead to a slower
conversion of the apo-PCPs. The velocities of the phospho-
pantetheinylation of TycC3_PCP(G42A) by Sfp(WT), and
TycC3_PCP(WT) by Sfp(Y36P) are rather enhanced compared
with the WT system. Although the presented data cannot
explain this finding, one might speculate that the reduced
affinity causes a faster dissociation of the holo-PCP/Sfp com-
plex after the reaction, which enables the enzyme to undergo
the next catalytic cycle faster. The conclusion that the hydrogen
bond between the carrier protein and the PPT is not essential
for the ppan transfer reaction is in agreement with results
showing that also the small YbbR peptide (Figure 5E),
mimicking only the second helix of a carrier protein, can be
phosphopantetheinylated on its own or when fused to other
proteins (Yin et al., 2005).
The structure of the PCP/Sfp complex suggests that the
hydrophobic interaction between PCP’s L46 and M49 located
in this helix and a more extended nonpolar patch in Sfp’s cata-
lytic domain is the key element of their interaction, which is
further supported by the mutational analysis. On the one hand,
the slow modification of TycC3_PCP(L46N) and the hardly
detectable formation of holo-TycC3_PCP(L46D) suggest that a552–562, April 24, 2014 ª2014 Elsevier Ltd All rights reserved 557
Figure 5. Protein-Protein Interactions in the Complex
(A) The binding of PCP (cyan) to Sfp (gray) is stabilized by hydrophobic interactions and an intermolecular hydrogen bond. The two interaction sites are linked by a
loop harboring a conserved glycine.
(B) The hydrogen bond (dashed line) is formed by Q40 of the PCP and Y36 in the N-terminal domain of Sfp. G42 in the loop of the PCP has a positive 4 torsion
(arrow), which might be necessary for the correct orientation of the two interaction sites.
(C) The side chains of L46 (green sticks) and M49 (yellow sticks) in the second helix of the PCP point toward a hydrophobic patch in the C-terminal PPT domain
(shown in electrostatic surface representation).
(D) A front view of this hydrophobic patch reveals a large cavity for binding of L46 (green circle) and a smaller one for M49 (yellow circle).
(legend continued on next page)
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Table 1. Thermodynamic Data from the ITC Experiments
Sample T (C) KD (mM) DH (kJ mol
1) DS (J mol1 K1) n
S45A + Sfp(WT)a 5 0.74 ± 0.04 15.6 ± 0.1 173.8 1.23 ± 0.01
S45A + Sfp(WT)a 25 0.92 ± 0.12 10.7 ± 0.1 80.0 1.22 ± 0.01
S45A + Sfp(Y36P)a 5 54.3 ± 6.5 18.2 ± 2.3 147.0 1.00 ± 0.10
S45A + Sfp(Y36P)a 25 – – – –
G42A/S45A + Sfp(WT)a 5b 39.7 ± 2.2 24.3 ± 1.2 171.7 1.08 ± 0.04
S45A/L46A + Sfp(WT)a 5/25 – – – –
S45A/L46N + Sfp(WT)a 5/25 – – – –
S45A/L46D + Sfp(WT)a 5/25 – – – –
S45A/M49D + Sfp(WT)a 5/25 – – – –
Sfp(WT) + CoA 5b 1.49 ± 0.17 16.4 ± 0.3 52.3 0.78 ± 0.01
Sfp(Y36P) + CoA 5b 1.57 ± 0.18 16.1 ± 0.2 53.2 1.10 ± 0.01
–, no apparent binding (KD > 100 mM). See also Figure S3 and Table S1.
a3 mM CoA in buffer.
bSample not stable at 25C.
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hand, the L46A mutation has a significant effect as well, as its
methyl group is too small to fill the binding pocket designed
for a larger side chain. PCP’s M49 does not point into such
a well-defined binding pocket, which is why its substitution
with an aspartate did not reduce the reaction velocity as strongly
as the same substitution for L46, emphasizing the central role
of PCP’s L46 for the binding to Sfp. The PCP mutants harboring
a mutation in helix 2 showed no detectable binding to Sfp(WT)
in the ITC titration experiments. This indicates that a
stronger reduction in affinity than was observed for either
TycC3_PCP(WT)/Sfp(Y36P) or TycC3_PCP(G42A)/Sfp(WT)
correlates with a slower reaction velocity. This correlation results
in an almost complete abolishment of the modification of
TycC3_PCP(L46N) when Sfp(WT) is substituted with Sfp(Y36P).
For the reaction of TycC3_PCP(L46N) with Sfp(WT), the hydro-
phobic interactions are significantly disturbed by the L46N
mutation, which leads to a slow reaction velocity. By an addi-
tional disruption of the intermolecular hydrogen bond, the apo-
TycC3_PCP(L46N)/Sfp(Y36P) complex, formed prior to the
reaction, is further destabilized and the reaction hardly occurs.
Thus, the intermolecular hydrogen bond seems to play an impor-
tant role in the modification of carrier proteins that would only
bind very weakly to Sfp via their second helix. Furthermore, the
hydrophobic character of the residues corresponding to L46
and M49 is conserved in many other carrier proteins involved
in different metabolic pathways (Figure 5E), emphasizing the
promiscuity of Sfp for diverse carrier proteins.
As carrier proteins are not only designed to be phosphopante-
theinylated but are also involved in substrate shuttling, and in
doing so act together with numerous other catalytic domains, it
makes sense that only a few residues are crucial for each inter-
domain contact to retain the great variety of interactions.(E) Alignments of Sfp with other group II PPTs from E. coli, Saccharomyces cerevis
S3075 in full-length TycC) with substrate carrier proteins of the PPTs, respectively
and protein-protein interaction (gray) are conserved. In addition, a glycine resid
presented structures, is also conserved (indicated with a 4). Similar hydrophobic
FAS from E. coli, Bacillus subtilis, and Spinacia oleracea, as well as in the small
Chemistry & Biology 21,SIGNIFICANCE
Sfp-like PPTs from pathogenic bacteria have been sug-
gested as potential drug targets (Leblanc et al., 2012; Yasgar
et al., 2010). The high similarity of the presented crystal
structure of the PCP/Sfp complex to the structure of the
human PPT/ACP complex suggests a potential problem in
the development of such drugs. The comparable orientation
of CoA and the carrier protein in the binding pockets of the
two PPTs indicates that cofactor binding, substrate recogni-
tion, and the mechanism of the ppan transfer are highly
conserved. Thus, a drug that inhibits a bacterial PPT by
directly targeting its active site may have similar effects on
the human PPT as well.
On the other hand, the similarities between the complexes
of PCP/Sfp and the human PPT/ACP emphasize the applica-
bility of group II PPTs in biotechnology. In principle, one
could develop an enormous variety of substances by
designing megasynthases that contain carrier proteins and
other domains from NRPS, PKS, and FAS. Due to their high
substrate tolerance with respect to the carrier protein,
group II PPTs such as Sfp seem ideal for modifying the
diverse ACPs and PCPs included in such artificial proteins.
However, until now, most attempts to design productive
megasynthases have not been very successful because
the selectivity of the interactions of the other domains is
not well understood and needs further investigation.EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of Sfp and PCP Variants
In this work, the previously described constructs of sfp in pQE60 (Mofid et al.,
1999) and tycC3_PCP in pQE70 (Weber et al., 2000) were used. Mutants ofiae, andHomo sapiens, and of TycC3_PCP (S45 in TycC3_PCP corresponds to
, show that the properties of the side chains involved in cofactor binding (black)
ue at the position of G42 of TycC3_PCP, which has a positive 4 angle in the
residues are also present in nonnatural substrates of Sfp, such as the ACPs of
YbbR peptide.
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Figure 6. Reaction Velocities of the ppan Transfer
Mutations of residues involved in the hydrophobic interaction reduce the
velocity of the ppan transfer (A), whereas disruption of the intermolecular
hydrogen bond accelerates the reaction (B). A small portion of
TycC3_PCP(G42A) precipitated during incubation, resulting in <100%product
formation even after 1 hr (Figure S4A), and making it appear that holo-
TycC3_PCP(G42A) formedmore slowly than it actually does. For better clarity,
error bars have been omitted because the SDs are rather small (i.e., max. 2.7%
in A and 3.5% in B).
See also Figure S3 and Table S1.
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procedures are described in Supplemental Experimental Procedures). All pQE
plasmids were transformed into Escherichia coli M15(pREP4) cells (QIAGEN).
For expression of Sfp variants, 500 ml lysogeny broth (LB) medium supple-
mented with 100 mg/l ampicillin and 30 mg/l kanamycin was inoculated with
5 ml of an overnight culture, and grown at 37C and 180 rpm. At an OD of
0.6, the temperature was lowered to 30C and expression was induced by
addition of isopropyl b-D-1-thiogalactopyranoside (IPTG) to a final concentra-
tion of 0.5 mM. After 4 hr, cells were harvested by centrifugation for 10 min at
6,000 rpm, resuspended in nickel buffer A (25 mM HEPES, 200 mM NaCl,
25 mM imidazole; pH 8.0), and lysed by ultrasonication. Proteins were purified
by nickel affinity purification with a linear imidazole gradient (buffer B: 25 mM
HEPES, 200 mM NaCl, 300 mM imidazole; pH 8.0), followed by dialysis and
size-exclusion chromatography with a Superdex 75 column (GE Healthcare)
in a suitable buffer.
Expression of nonlabeled PCP constructs was performed similarly at 20C
overnight, and the purification was done in the same way as described for
Sfp. Isotopic-labeled samples were produced accordingly in M9 minimal me-
dium supplemented with 1 g/l 15N-ammonium chloride and 2 g/l 13C-glucose.
Cell-free Expression and Purification of PCP Variants
Since the PCP variants harboring a glycine-to-alanine mutation showed no
expression under several tested conditions, the genes were subcloned into
the pBH4 vector (a pET15b variant with a cleavable N-terminal 6xHis tag).
Again, no expression in vivo using E. coli BL21(DE3) cells (New England
Biolabs) was observed, but the vector could be used for a T7 RNA polymer-
ase-based transcription/translation cell-free expression system (Schwarz
et al., 2007) to facilitate the production of insoluble proteins. These proteins
were dissolved in 6 M urea and refolded by dialysis against 25 mM HEPES,
50 mM NaCl, 1 mM dithiothreitol (DTT), 0.5 mM EDTA (pH 7.2) at 4C. The
refolded proteins were treated with tobacco etch virus protease for 12–16 hr
at 4C and purified by reverse nickel affinity purification and subsequent dial-560 Chemistry & Biology 21, 552–562, April 24, 2014 ª2014 Elsevierysis and size-exclusion chromatography analogously to the in vivo expressed
proteins.
As a control, TycC3_PCP(WT) and TycC3_PCP(S45A) were also subcloned
into pBH4 and expressed cell free, resulting in insoluble proteins that were
purified like the G42A mutants.
Crystallization, Data Collection, and Structure Determination of the
PCP/Sfp Complex
TycC3_PCP(S45A) and Sfp(WT) were purified separately in 25 mM HEPES,
50 mM NaCl, 5 mM MgCl2, and 5 mM DTT (pH 7.2), and mixed at a 1:1 molar
ratio. CoA was added to the protein mixture to a final concentration of 1.5 mM.
Final mixtures with monomer concentrations of 300, 500, and 750 mM were
used for crystallization.
Diffraction-quality crystals were grown using the sitting-drop method by a
Mosquito crystallization robot (TTP LabTech), with 0.16Mmagnesium acetate,
0.08 M sodium cacodylate (pH 6.5), 16% (w/v) PEG 8000, and 20% (v/v)
glycerol in the reservoir solution. The crystals formed overnight and were full
grown within 3–4 days at 20C. Preliminary diffraction data were collected to
2.6 A˚ resolution at the Max Planck Institute of Biophysics (Frankfurt, Germany)
using the FR-E+ in-house diffractometer equipped with a Saturn 994+ CCD
detector (Rigaku). The diffraction data were processed using HKL2000 (Evans,
2006). A preliminary structure of the complex was solved by employing the
molecular replacement method using MOLREP from the CCP4 package
(Winn et al., 2011), with the structure of the Sfp (PDB 1QR0) and the presented
NMR structure as search models.
A data set of the crystals obtained by reproducing the previous conditions in
hanging drops was collected at the PX3 beamline of the Swiss Light Source
(Villigen, Switzerland). The diffraction data were processed using MOSFLM
(Leslie and Powell, 2007) and the complex structure was determined by the
molecular replacement method using the preliminary model obtained earlier
from the data collected at the in-house diffractometer as a search model.
The model was further built and refined using COOT (Emsley and Cowtan,
2004) and REFMAC5 (Murshudov et al., 2011), respectively. Data collection
and refinement statistics are summarized in Table S2.
NMR Structure Determination
Resonance assignment of TycC3_PCP(S45A) was performed using triple-
resonance spectra recorded at 298 K with a 700 mM uniformly [13C; 15N]-
labeled protein sample in 50 mM sodium phosphate (NaPi) buffer (pH 6.8)
containing 5% D2O and 0.15 mM 4,4-dimethyl-4-silapentane-1-sulfonate
(DSS). All data were collected on Bruker Avance 600-950 MHz spectrometers
equipped with triple-resonance cryo probes.
The completeness of the chemical-shift assignments for the nonlabile 1H
and the backbone HN was 94%. 3D 15N-resolved NOE spectroscopy/hetero-
nuclear single-quantum coherence (NOESY-HSQC) and 13Caromatic-resolved
NOESY-HSQC spectra yielded peak lists from which NOE distance restraints
were obtained by automatic NOESY cross-peak assignment and calibration
using the program CYANA (Gu¨ntert, 2009; Herrmann et al., 2002) based on
the chemical-shift lists (Table S3). Backbone dihedral angle restraints were
created from chemical-shift data for the atoms HN, N, C’, Ca, Cb, and Ha using
TALOS+ software (Shen et al., 2009).
The structure calculation was performed with CYANA using 100 random
starting conformers and 10,000 torsion-angle dynamics steps. From the
resulting structures, the 20 with the lowest target function values were
selected. Restrained energy refinement was carried out using the OPALp
program (Koradi et al., 2000).
Phosphopantetheinylation Assay
Proteins used in the phosphopantetheinylation assay were purified into 50mM
NaPi (pH 6.8), 5 mM DTT, and 5 mM MgCl2. The concentration of the PCP
variants was adjusted to 105 mM and aliquots of 95 ml were made. The priming
reaction, performed in triplicate, was started by adding 5 ml enzymemix (10 mM
Sfp/20 mM CoA) to each aliquot, and incubated at 25C. The reaction was
stopped with 100 ml precooled trichloroacetic acid (20% w/v) after the desired
reaction time. The precipitates were pelleted by centrifugation for 30 min at
20,000 3 g and 4C, washed with 200 ml trichloroacetic acid followed by
200 ml diethyl ether, and dried in a centrifugal evaporator.Ltd All rights reserved
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0.1% v/v) and applied on a CC250/3 Nucleosil 120-3 C18 column
(Macherey-Nagel) operated at 50C. The separation of apo- and holo-PCPs
was accomplished using a linear gradient from 45%–54.5% buffer B (45%–
59% for the pBH4 constructs) over 27 min at a flow rate of 0.8 ml/min with
0.1% (v/v) TFA in water or acetonitrile as buffer A and buffer B, respectively.
The different compounds were identified by electrospray ionization/mass
spectrometry analysis with a detection range for m/z of 400–1,400, and quan-
tified by their absorption at 214 nm measured in parallel.
Complex Stability Analysis
After purification, all PCP and Sfp variants were dialyzed against 50 mM NaPi
(pH 6.8) and 5 mM MgCl2. Using a Slide-A-Lyzer dialysis cassette with a
3,500 Da cutoff (Thermo Scientific), a 100 mM CoA solution was subjected
to the same dialysis.
For a first set of experiments, the proteins were diluted with dialysis buffer
and supplemented with CoA and tris(2-carboxyethyl)phosphine (TCEP) to
gain solutions with final concentrations of 50 mM PCP or 800 mM Sfp variant,
3 mM CoA and 2 mM TCEP. Active-site single- and double-mutant PCPs
were injected into a VP-ITC calorimeter (MicroCal) and Sfp(WT) was titrated
in 27 steps of 10 ml each, at both 5C and 25C. Sfp(Y36P) was titrated to
the active-site mutant PCP in exactly the same manner.
For a second set of experiments, solutions of 50 mM Sfp (WT and Y36P) and
800 mMCoA, all with 2 mM TCEP, were prepared. CoA was titrated to both Sfp
variants in 27 titration steps of 10 ml, but due to the reduced thermal stability of
both Sfp variants in the absence of CoA, these experiments were only per-
formed at 5C.
ACCESSION NUMBERS
The atomic coordinates and structure factors of the PCP/Sfp complex struc-
ture, and the atomic coordinates and NMR restraints of TycC3_PCP(S45A)
have been deposited in the Protein Data Bank under accession numbers
4MRT and 2MD9, respectively. The resonance assignment for the NMR struc-
ture can be found in the Biological Magnetic Resonance Bank under accession
number 19479.
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